Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-02234 · Session 1

What factors have been identified to explain why the five year survival rate from lung cancer in Scotland is approximately 6%, the European…

Answered Asked by Alex Fergusson Con Lodged 28 Oct 1999

The question

To ask the Scottish Executive what factors have been identified to explain why the five year survival rate from lung cancer in Scotland is approximately 6%, the European average is approximately 10% and the USA average is 14% and what action is proposed to address this situation.

The answer

Answered by Susan Deacon on 19 Jan 2000 · 83 days after it was lodged, 69 days after it was due

Variations in reported survival figures may be due in part to known differences in the way cancer registration data are collected in other countries. However, research tends to suggest that some of the difference must be due to late presentation by individuals to seek a medical opinion once symptoms suggestive of lung cancer appear.The association between smoking and lung cancer is well known. By encouraging people to stop smoking
- or not to start smoking
- we are aiming to stop people contracting lung cancer in the first place. For those people who do develop lung cancer it is imperative that they seek medical advice as soon as any symptoms suggestive of the disease appear.The Scottish Executive is committed to reducing deaths from all cancers by 20% by 2010 (against the 1995 baseline). To meet that target it is necessary to look at early presentation and promoting better health by raising awareness of the benefits of improved diet and otherwise healthier lifestyles on which major initiatives are currently underway. The emerging managed cancer clinical networks, comprising specialists and clinicians from all disciplines working together to ensure that everyone has access to the best quality of care possible, will provide the focus for continuous improvements in care underpinned by prospective clinical audit. Arrangements are in hand to establish these networks across the country, the first phase of which is concentrating on lung cancer (as well as breast, colorectal and gynaecological cancers).

In the Official Report

No contribution in the Official Report cites S1W-02234 by reference.